<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE327nnn/GSE327270/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Methylation profiling</omics_type><species>Homo sapiens</species><gds_type>Methylation profiling by genome tiling array</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE327270</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Semaglutide Slows Epigenetic Aging in a Randomized Trial of HIV-Associated Lipohypertrophy</name><description>Genome-wide DNA methylation profiling of PBMC samples from people living with HIV HIV-1 infection impacts biological aging, and epigenetic clocks highlight epigenetic age acceleration in people with HIV. Despite evidence indicating Glucagon-like peptide-1 receptor agonist in beneficial HIV-associated cardiometabolic outcomes, effects on aging biomarkers in HIV epigenetic studies is a major gap in knowledge. Hence, we generated a representative epigenetic dataset to examine Glucagon-like peptide-1 receptor agonist in epigenetic ageing and relationships to clinical phenotypes.</description><dates><publication>2026/04/17</publication></dates><accession>GSE327270</accession><cross_references><GSM>GSM9652617</GSM><GSM>GSM9652618</GSM><GPL>33022</GPL><GSE>327270</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>